Signaling Path May Lead to Better Heart-Failure Therapies
- 17 April 1998
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 280 (5362) , 383
- https://doi.org/10.1126/science.280.5362.383
Abstract
An overstressed heart muscle tries to compensate by growing bigger. But although this strategy works at first, the muscle eventually loses its elasticity; in this state, called congestive heart failure, the heart is inefficient at pumping blood and prone to arrhythmias that cause sudden death. In today9s issue of Cell, a research team reports finding an internal signaling pathway in cardiac muscle cells that, when pushed into overdrive, can cause heart failure in mice. What9s more, the team showed that the immunosuppressive drug cyclosporin A inhibits this pathway, blocking heart failure in the animals. If the same pathway plays a similar role in human heart failure, it may be possible to halt or even reverse the condition, either with cyclosporin A or other drugs that can inhibit the pathway.This publication has 0 references indexed in Scilit: